Scilex Holding (SCLX) Common Equity (2020 - 2026)

Scilex Holding (SCLX) posted quarterly Common Equity of -$254.1 million for Q1 2026, down 20.14% year-over-year from -$318.1 million in Q1 2025, and down 19.98% on a QoQ basis from -$211.8 million in Q4 2025.

Scilex Holding (SCLX) Common Equity (2020 - 2026) Analysis & Trends

Scilex Holding (SCLX) has reported Common Equity for 7 consecutive years, with -$254.1 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Common Equity fell 20.14% year-over-year to -$254.1 million; the TTM figure through Mar 2026 stood at -$254.1 million (down 20.14% YoY), while the FY2025 annual figure was -$211.8 million, down 9.92% from the prior year.
  • Common Equity came in at -$254.1 million for Q1 2026 at Scilex Holding, down from -$211.8 million in the prior quarter.
  • The five-year high for Common Equity was $36.2 million in Q4 2022, with the low at -$254.1 million in Q1 2026.
  • Average Common Equity over 5 years is -$170.7 million, with a median of -$211.3 million recorded in 2024.
  • The largest YoY upside for Common Equity was 116.19% in 2022 against a maximum downside of 2906.36% in 2022.
  • Year by year, Common Equity stood at $36.2 million in 2022, then plunged by 577.22% to -$172.9 million in 2023, then slipped by 11.39% to -$192.6 million in 2024, then fell by 9.92% to -$211.8 million in 2025, then retreated by 19.98% to -$254.1 million in 2026.
  • According to Business Quant data, Common Equity over the past three periods registered -$254.1 million, -$211.8 million, and -$176.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 31.20 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 81.19 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -6.61 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 47.38 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 45.93 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 9.19 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 23.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 90.40 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Scilex Holding 54.30 Mn -95.62 Mn 4.15 Mn -254.07 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -254.07 Mn
Dec 31, 2025 -211.75 Mn
Sep 30, 2025 -176.94 Mn
Jun 30, 2025 -248.99 Mn
Mar 31, 2025 -211.48 Mn
Dec 31, 2024 -192.64 Mn
Sep 30, 2024 -211.32 Mn
Jun 30, 2024 -214.69 Mn
Mar 31, 2024 -189.79 Mn
Dec 31, 2023 -172.94 Mn
Sep 30, 2023 -162.67 Mn
Jun 30, 2023 10.42 Mn
Mar 31, 2023 11.08 Mn
Dec 31, 2022 36.24 Mn
Sep 30, 2022 -229.40 Mn
Jun 30, 2022 -252.10 Mn
Mar 31, 2022 -231.57 Mn
Dec 31, 2021 -223.88 Mn
Sep 30, 2021 -9.83 Mn
Jun 30, 2021 -8.39 Mn